Vicarious Surgical to Present at the Canaccord Genuity 43rd Annual Growth Conference
03 Agosto 2023 - 5:30PM
Business Wire
Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”)
(NYSE: RBOT, RBOT WS), a next-generation robotics technology
company seeking to improve patient outcomes as well as both cost
and efficiency of surgical procedures, today announced the Company
will participate in the Canaccord Genuity 43rd Annual Growth
Conference.
Management is scheduled to present on Wednesday, August 9 at
2:30 p.m. ET. A live webcast of the presentation will be accessible
to the public on the “Investors” section of the Company’s website
at https://investor.vicarioussurgical.com. An archive of the
webcast will be available for replay following the conference.
About Vicarious Surgical
Founded in 2014, Vicarious Surgical is a next generation
robotics company developing a disruptive technology with the goals
of increasing the efficiency of surgical procedures, improving
patient outcomes, and reducing healthcare costs. The Company’s
novel surgical approach uses proprietary human-like surgical robots
to transport surgeons inside the patient to perform minimally
invasive surgery. The Company is led by an experienced team of
technologists, medical device professionals and physicians, and is
backed by technology luminaries including Bill Gates, Vinod
Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME
Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15
VC. The Company is headquartered in Waltham, Massachusetts. Learn
more at www.vicarioussurgical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230803405108/en/
Investor Contact Kaitlyn Brosco
Kbrosco@vicarioussurgical.com
Marissa Bych Gilmartin Group Marissa@gilmartinir.com
Press and Media Inquiries: Abby Mayo for Matter Health
media@vicarioussurgical.com
Vicarious Surgical (NYSE:RBOT)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Vicarious Surgical (NYSE:RBOT)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025